Authors:
CRAWFORD J
BLACKWELL S
SHOEMAKER D
PUPA MR
MULHAUSEN T
HERNDON J
WINER E
FLYNN J
DEMPSEY H
Citation: J. Crawford et al., PREVENTION OF CHEMOTHERAPY-RELATED ANEMIA BY RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) RECEIVING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CAE) CHEMOTHERAPY WITHG-CSF SUPPORT, Blood, 84(10), 1994, pp. 10000129-10000129
Authors:
RUTHERFORD CJ
SCHNEIDER TJ
DEMPSEY H
KIRN DH
BRUGNARA C
GOLDBERG MA
Citation: Cj. Rutherford et al., EFFICACY OF DIFFERENT DOSING REGIMENS FOR RECOMBINANT-HUMAN-ERYTHROPOIETIN IN A SIMULATED PERISURGICAL SETTING - THE IMPORTANCE OF IRON AVAILABILITY IN OPTIMIZING RESPONSE, The American journal of medicine, 96(2), 1994, pp. 139-145
Authors:
MILLER AM
DEMPSEY H
WEINER RS
GROSS S
GRAHAMPOLE J
OBLON DJ
GREENE V
MYERS L
GROSS MA
HUTCHESON C
Citation: Am. Miller et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) DOES NOT PROMOTE STEM-CELL STEAL FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANT, Blood, 82(10), 1993, pp. 10000638-10000638